A high-energy trade mark dispute has gone to the Federal Court after the maker of Mother energy drinks lost its bid before IP Australia to prevent a Victoria-based company from registering Kangaroo Mother as a trade mark for beverages.
The former director of Sydney financial planning practice Hillross Bella Vista has been conditionally released without a conviction recorded after pleading guilty to falsifying documents uncovered during an investigation by the Australian Securities and Investments Commission.
Law firm Hall & Wilcox has snagged a new partner from Norton Rose Fulbright to join its construction and project disputes team, as part of an ambitious national growth strategy.
The judge overseeing class actions against Commonwealth Bank over its money laundering compliance failures has threatened to force the parties to go to trial by a certain date if they can’t agree to “sensible” time limits to ready the case for hearing, noting he would reach retirement age in 2024.
A judge has slammed an “absurd” class action settlement offer made by pelvic mesh device maker Astora Women’s Health that would require Shine Lawyers to provide the company with indemnities, saying “no rational judge” would approve it.
The Office of the Australian Information Commissioner is investigating whether Optus breached privacy law after the telco wrongly published customers’ personal details in the White Pages in 2019.
A solicitor who admitted to allegations of professional misconduct has lost a NSW Court of Appeal bid for the costs of a NCAT proceeding to be paid from the state’s Public Purpose Fund, despite twice winning appeals of the tribunal’s findings.
A judge has dismissed jailed property developer Salim Mehajer’s defamation lawsuit against broadcaster Seven, saying delays in fixing significant defects in his case amounted to an abuse of process.
Sydney’s ongoing COVID-19 lockdown has created “logistical” difficulties delaying the release of a long awaited judgment in the ACCC’s consumer law case against collapsed private college Phoenix Institute, which was accused of misleading students through the marketing of its courses.
Pharmaceutical giant Bristol-Myers Squibb will fight a case brought by Merck Sharp & Dohme alleging misuse of market power over stage IV melanoma treatments, telling the Federal Court on Friday it denied its rival’s claims.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
